Synchrony® Raises the Bar in AAPM MArkerless Lung Target Tracking Challenge (MATCH)

Interested in a Synchrony Demo?

Delivering effective and safe lung cancer stereotactic body radiation therapy (SBRT) requires technology that can account for lung tumor motion. Request a demo to see firsthand how Synchrony achieves superior precision and accuracy in the treatment of moving targets.

MATCH Compares Markerless Tracking Technologies

Delivering effective and safe lung cancer stereotactic body radiation therapy (SBRT) requires technology that can account for lung tumor motion. Both fiducial-based and markerless tracking algorithms currently exist, with markerless being a focus of innovation, investment and research in the field. These tracking algorithms, however, have not been benchmarked using a common, prospective measurement methodology. The American Association of Physicists in Medicine (AAPM) designed the MArkerless Lung Target Tracking CHallenge (MATCH), an AAPM Grand Challenge, to compare the precision and accuracy of existing markerless tracking algorithms.

Synchrony Markerless Lung Tracking Provides Clinical Benefits such as Enhanced Precision and Accuracy

Accuray customers, using the Accuray Synchrony® Lung Tracking™ with Respiratory Modeling on the Radixact® System, the next-generation TomoTherapy® platform, and CyberKnife® System, achieved the highest levels of accuracy and precision, taking top honors in the AAPM MATCH challenge.

Learn How Synchrony Achieves Superior Precision & Accuracy in the Treatment of Moving Targets

Register and watch the webinar to learn how Montefiore Einstein Center for Cancer Care (MECCC) uses Synchrony technology to achieve superior precision and accuracy with markerless tracking, delivering better patient outcomes while streamlining clinical complexity. The webinar features Lee Goddard, MPhys, DABR, physicist at MECC.